However, Daly et al. found that Ang-2 blockade inhibited tumor growth by decreasing Tie-2 activity indicating that Ang-2 could function as a Tie-2 agonist in tumor xenograft models [27, 28]. Here, ANGPT2 is linked to neoplasm.